Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sphingolipids in ocular inflammation.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Erratum.
Teva targets $4 billion lupus market with laquinimod study
UCSF Neuroimmunology Seminar
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
[Charcot and his legacy to medicine].
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
Dimethyl fumarate - only an anti-psoriatic medication?
PML risk stratification using anti-JCV antibody index and L-selectin.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
[Association between depression and cognitive decline in sclerosis multiplex patients].
FTY720 attenuates excitotoxicity and neuroinflammation.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Imaging of microglia in patients with neurodegenerative disorders.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Pages
« first
‹ previous
…
252
253
254
255
256
257
258
259
260
…
next ›
last »